EUVIMEDEUVIMED entdecken
Crossref

Oral Liposomal Iron: A Promising New Strategy for Anemia Management in Clinical Practice

Biomedical Science and Clinical Research · 2023

DOI: 10.33140/bscr.02.02.08 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Science and Clinical Research, 2023.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anemia is a public health problem affecting about a third of the world’s population, the major cause of it being iron deficiency. The many oral iron preparations available at present, are inadequate due to intolerance, or contraindications. IV iron preparations are painful, require patient monitoring and carry the risk of anaphylaxis. Iron salts like Iron pyrophosphate are covered with liposome, a spherical structure of a phospholipidic nature that is similar to those human cell membranes. The bioavailability of liposomal pyrophosphate iron is 3.5 times greater than the free pyrophosphate iron, 2.7 times higher than iron sulfate, and 4.1 times higher compared with iron gluconate. Clinical studies showed that oral liposomal iron is a safe and efficacious alternative to correct anaemia, as also it is a viable treatment option for iron deficiency anaemia in pregnant women.

Zitieren

APA

(2023). Oral Liposomal Iron: A Promising New Strategy for Anemia Management in Clinical Practice. Biomedical Science and Clinical Research. https://doi.org/10.33140/bscr.02.02.08

Vancouver

Oral Liposomal Iron: A Promising New Strategy for Anemia Management in Clinical Practice. Biomedical Science and Clinical Research. 2023. doi:10.33140/bscr.02.02.08

BibTeX
@article{euvimed2023,
  title = {Oral Liposomal Iron: A Promising New Strategy for Anemia Management in Clinical Practice},
  journal = {Biomedical Science and Clinical Research},
  year = {2023},
  doi = {10.33140/bscr.02.02.08}
}
Kostenlos starten →